HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$7.02
Day range
$6.89 - $7.69
Year range
$5.35 - $17.58
Market cap
408.83M USD
Avg Volume
920.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 22.61M | 707.07% |
Operating expense | 36.27M | 11.98% |
Net income | -10.48M | 61.12% |
Net profit margin | -46.35 | 95.18% |
Earnings per share | -0.18 | 70.00% |
EBITDA | -13.13M | 54.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 216.90M | 7.70% |
Total assets | 271.56M | 18.92% |
Total liabilities | 42.53M | -38.16% |
Total equity | 229.02M | — |
Shares outstanding | 54.08M | — |
Price to book | 1.66 | — |
Return on assets | -12.08% | — |
Return on capital | -14.49% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.48M | 61.12% |
Cash from operations | -23.19M | -12.32% |
Cash from investing | 819.00K | -94.46% |
Cash from financing | 568.00K | -92.26% |
Net change in cash | -21.81M | -1,588.46% |
Free cash flow | -12.09M | -161.18% |
About
Founded
2014
Headquarters
Website
Employees
128
